ArticleOncotarget2018

Correction: Colon cancer-induced interleukin-35 inhibits betacatenin- mediated pro-oncogenic activity.

Yueqiang Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.